BACKGROUND: Mycoplasma genitalium is a common infection of the genitourinary tract, but its pathogenic effects have not been well described, especially in women. The increasing evidence that M. genitalium is associated with HIV infection calls for an urgent consensus on how best to control this infection. The aim of this study was to describe symptoms and signs associated with M. genitalium infection among high-risk women in Uganda. METHODS: A cohort of 1027 female sex workers was recruited in Kampala in 2008. At enrollment, HIV testing was performed, genital specimens were tested for other sexually transmitted infection, and urogenital symptoms and signs were recorded. Endocervical swabs were tested for M. genitalium using a commercial Real-TM PCR assay (Sacace Biotechnologies, Como, Italy). The associations of clinical signs and symptoms with prevalent M. genitalium were investigated using multivariable logistic regression models. RESULTS: Reported dysuria and presence of mucopurulent vaginal discharge were significantly associated with M. genitalium infection (OR: 1.85, 95% confidence interval: 1.13-3.03 and OR: 1.55, 95% confidence interval: 1.06-2.29, respectively). There was little evidence for an association with cervicitis or with pelvic inflammatory disease. CONCLUSIONS: In this specific population, we found evidence that symptoms of urethritis and mucopurulent vaginal discharge were associated with M. genitalium infection. This supports earlier studies showing that M. genitalium may lead to clinically relevant genitourinary disorders and should be treated. In the absence of sensitive screening tests, further work is needed to validate clinical findings as possible indicators of M. genitalium infection to guide a possible syndromic approach for its control.
BACKGROUND: Mycoplasma genitalium is a common infection of the genitourinary tract, but its pathogenic effects have not been well described, especially in women. The increasing evidence that M. genitalium is associated with HIV infection calls for an urgent consensus on how best to control this infection. The aim of this study was to describe symptoms and signs associated with M. genitalium infection among high-risk women in Uganda. METHODS: A cohort of 1027 female sex workers was recruited in Kampala in 2008. At enrollment, HIV testing was performed, genital specimens were tested for other sexually transmitted infection, and urogenital symptoms and signs were recorded. Endocervical swabs were tested for M. genitalium using a commercial Real-TM PCR assay (Sacace Biotechnologies, Como, Italy). The associations of clinical signs and symptoms with prevalent M. genitalium were investigated using multivariable logistic regression models. RESULTS: Reported dysuria and presence of mucopurulent vaginal discharge were significantly associated with M. genitalium infection (OR: 1.85, 95% confidence interval: 1.13-3.03 and OR: 1.55, 95% confidence interval: 1.06-2.29, respectively). There was little evidence for an association with cervicitis or with pelvic inflammatory disease. CONCLUSIONS: In this specific population, we found evidence that symptoms of urethritis and mucopurulent vaginal discharge were associated with M. genitalium infection. This supports earlier studies showing that M. genitalium may lead to clinically relevant genitourinary disorders and should be treated. In the absence of sensitive screening tests, further work is needed to validate clinical findings as possible indicators of M. genitalium infection to guide a possible syndromic approach for its control.
Authors: Erica M Lokken; Jennifer E Balkus; James Kiarie; James P Hughes; Walter Jaoko; Patricia A Totten; R Scott McClelland; Lisa E Manhart Journal: Am J Epidemiol Date: 2017-07-15 Impact factor: 4.897
Authors: Lisa M Vallely; Pamela Toliman; Claire Ryan; Glennis Rai; Johanna Wapling; Josephine Gabuzzi; Joyce Allen; Christine Opa; Gloria Munnull; Petronia Kaima; Benny Kombuk; Antonia Kumbia; Zure Kombati; Greg Law; Angela Kelly-Hanku; Handan Wand; Peter M Siba; Glen D L Mola; John M Kaldor; Andrew J Vallely Journal: BMJ Open Date: 2017-12-29 Impact factor: 2.692
Authors: Judith Vandepitte; Helen A Weiss; Nassim Kyakuwa; Susan Nakubulwa; Etienne Muller; Anne Buvé; Patrick Van der Stuyft; Richard Hayes; Heiner Grosskurth Journal: Sex Transm Dis Date: 2013-05 Impact factor: 2.830
Authors: Elizabeth Olson; Kanupriya Gupta; Barbara Van Der Pol; James W Galbraith; William M Geisler Journal: Int J STD AIDS Date: 2021-07-06 Impact factor: 1.359
Authors: Kristen R Moore; Meena Tomar; Brandie D Taylor; Scott E Gygax; David W Hilbert; Donna D Baird Journal: Sex Transm Dis Date: 2021-02-01 Impact factor: 3.868